Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
AbbVie
AbbVie
Viome
Alliance Foundation Trials, LLC.
Stanford University
Hutchmed
The Cleveland Clinic
W.L.Gore & Associates
Johann Wolfgang Goethe University Hospital
Boston Medical Center
AbbVie
Odense University Hospital
Integra LifeSciences Corporation
University Health Network, Toronto